BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zlobec I, Molinari F, Martin V, Mazzucchelli L, Saletti P, Trezzi R, De Dosso S, Vlajnic T, Frattini M, Lugli A. Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. World J Gastroenterol 2010; 16(38): 4823-4831 [PMID: 20939111 DOI: 10.3748/wjg.v16.i38.4823]
URL: https://www.wjgnet.com/1007-9327/full/v16/i38/4823.htm
Number Citing Articles
1
Bojana Mitrovic, David F Schaeffer, Robert H Riddell, Richard Kirsch. Tumor budding in colorectal carcinoma: time to take noticeModern Pathology 2012; 25(10): 1315 doi: 10.1038/modpathol.2012.94
2
Bojana Mitrovic, Kelly Handley, Naziheh Assarzadegan, Hector Li Chang, Heather A.E. Dawson, Andrea Grin, Gordon G.A. Hutchins, Laura Magill, Philip Quirke, Robert H. Riddell, Richard G Gray, Richard Kirsch. Prognostic and Predictive Value of Tumor Budding in Colorectal CancerClinical Colorectal Cancer 2021; 20(3): 256 doi: 10.1016/j.clcc.2021.05.003
3
Rani Kanthan, Jenna-Lynn Senger, Selliah Chandra Kanthan. Molecular Events in Primary and Metastatic Colorectal Carcinoma: A ReviewPathology Research International 2012; 2012: 1 doi: 10.1155/2012/597497
4
Valeria Maffeis, Lorenzo Nicolè, Rocco Cappellesso. RAS, Cellular Plasticity, and Tumor Budding in Colorectal CancerFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01255
5
Rondell P. Graham, Robert A. Vierkant, Lori S. Tillmans, Alice H. Wang, Peter W. Laird, Daniel J. Weisenberger, Charles F. Lynch, Amy J. French, Susan L. Slager, Yassaman Raissian, Joaquin J. Garcia, Sarah E. Kerr, Hee Eun Lee, Stephen N. Thibodeau, James R. Cerhan, Paul J. Limburg, Thomas C. Smyrk. Tumor Budding in Colorectal CarcinomaAmerican Journal of Surgical Pathology 2015; 39(10): 1340 doi: 10.1097/PAS.0000000000000504
6
Manabu Takamatsu, Hiroshi Kawachi, Noriko Yamamoto, Maki Kobayashi, Yuka Toyama, Takashi Maekawa, Akiko Chino, Shoichi Saito, Masashi Ueno, Yutaka Takazawa, Yuichi Ishikawa. Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic methodModern Pathology 2019; 32(5): 675 doi: 10.1038/s41379-018-0189-1
7
Annette Arndt, Klaus Kraft, Eva Wardelmann, Konrad Steinestel. Lack of Association between Membrane-Type 1 Matrix Metalloproteinase Expression and Clinically Relevant Molecular or Morphologic Tumor Characteristics at the Leading Edge of Invasive Colorectal CarcinomaBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/185404
8
Sejin Jang, Mineui Hong, Mi Kyung Shin, Byung Chun Kim, Hyung-Sik Shin, Eunsil Yu, Seung-Mo Hong, Jihun Kim, Sung-Min Chun, Tae-Im Kim, Kyung-Chan Choi, Young Woong Ko, Jeong Won Kim. KRAS and PIK3CA mutations in colorectal adenocarcinomas correlate with aggressive histological features and behaviorHuman Pathology 2017; 65: 21 doi: 10.1016/j.humpath.2017.01.010
9
Soo-Jin Cho, Sanjay Kakar. Tumor Budding in Colorectal Carcinoma: Translating a Morphologic Score Into Clinically Meaningful ResultsArchives of Pathology & Laboratory Medicine 2018; 142(8): 952 doi: 10.5858/arpa.2018-0082-RA
10
Viktor H Koelzer, Inti Zlobec, Alessandro Lugli. Tumor budding in the clinical management of colon and rectal cancerColorectal Cancer 2014; 3(4): 387 doi: 10.2217/crc.14.21
11
Alexandru Grigore, Mohit Jolly, Dongya Jia, Mary Farach-Carson, Herbert Levine. Tumor Budding: The Name is EMT. Partial EMT.Journal of Clinical Medicine 2016; 5(5): 51 doi: 10.3390/jcm5050051
12
Han-Na Kim, Soo Yeon Lee, Baek-hui Kim, Chung-Yeul Kim, Aeree Kim, Hayeon Kim. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring systemVirchows Archiv 2021; 478(6): 1071 doi: 10.1007/s00428-020-03012-2
13
Alessandro Lugli, Tatjana Vlajnic, Olivier Giger, Eva Karamitopoulou, Efstratios S. Patsouris, George Peros, Luigi M. Terracciano, Inti Zlobec. Intratumoral budding as a potential parameter of tumor progression in mismatch repair–proficient and mismatch repair–deficient colorectal cancer patientsHuman Pathology 2011; 42(12): 1833 doi: 10.1016/j.humpath.2011.02.010
14
Kyra B Berg, David F Schaeffer. Tumor budding as a standardized parameter in gastrointestinal carcinomas: more than just the colonModern Pathology 2018; 31(6): 862 doi: 10.1038/s41379-018-0028-4
15
Inti Zlobec, Alessandro Lugli. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotargetOncotarget 2010; 1(7): 651 doi: 10.18632/oncotarget.199
16
Bruno Märkl, Hans M Arnholdt. Prognostic significance of tumor budding in gastrointestinal tumorsExpert Review of Anticancer Therapy 2011; 11(10): 1521 doi: 10.1586/era.11.156
17
Marssoni Deconto Rossoni, José Ederaldo Queiroz Telles, Andrea Maciel de Oliveira Rossoni, Jorge Eduardo Fouto Matias. Risk factors for recurrence of stage I/II (TNM) colorectal adenocarcinoma in patients undergoing surgery with curative intentJournal of Coloproctology 2013; 33(01): 028 doi: 10.1016/j.jcol.2013.02.002
18
Jung Ho Kim, Jeong Mo Bae, Young Seok Song, Nam-Yun Cho, Hye Seung Lee, Gyeong Hoon Kang. Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinomaOncotarget 2016; 7(12): 13372 doi: 10.18632/oncotarget.5618
19
Yuji Konishi, Futoshi Kawamata, Hiroshi Nishihara, Shigenori Homma, Yasutaka Kato, Masumi Tsuda, Shinji Kohsaka, Takahiro Einama, Cheng Liu, Tadashi Yoshida, Akihisa Nagatsu, Mishie Tanino, Shinya Tanaka, Hideki Kawamura, Toshiya Kamiyama, Akinobu Taketomi. Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinomaMedical Oncology 2018; 35(7) doi: 10.1007/s12032-018-1164-x
20
A. Greystoke, S. A. Mullamitha. How Many Diseases Are Colorectal Cancer?Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/564741
21
Keita Kai, Shinichi Aishima, Shigehisa Aoki, Yukari Takase, Kazuyoshi Uchihashi, Masanori Masuda, Aki Nishijima-Matsunobu, Mihoko Yamamoto, Kousuke Ide, Atsushi Nakayama, Makiko Yamasaki, Shuji Toda. Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancerPathology International 2016; 66(2): 75 doi: 10.1111/pin.12374
22
Ola Marzouk, John Schofield. Review of Histopathological and Molecular Prognostic Features in Colorectal CancerCancers 2011; 3(2): 2767 doi: 10.3390/cancers3022767
23
Derek J. Erstad, Gerald Tumusiime, James C. Cusack. Prognostic and Predictive Biomarkers in Colorectal Cancer: Implications for the Clinical SurgeonAnnals of Surgical Oncology 2015; 22(11): 3433 doi: 10.1245/s10434-015-4706-x
24
Anne Trinh, Claudia Lädrach, Heather E. Dawson, Sanne ten Hoorn, Peter J. K. Kuppen, Marlies S. Reimers, Miriam Koopman, Cornelis J. A. Punt, Alessandro Lugli, Louis Vermeulen, Inti Zlobec. Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) dataBritish Journal of Cancer 2018; 119(10): 1244 doi: 10.1038/s41416-018-0230-7
25
Massimo Pancione, Andrea Remo, Vittorio Colantuoni. Genetic and Epigenetic Events Generate Multiple Pathways in Colorectal Cancer ProgressionPathology Research International 2012; 2012: 1 doi: 10.1155/2012/509348
26
Mineui Hong, Jeong Won Kim, Mi Kyung Shin, Byung Chun Kim. Poorly Differentiated Clusters in Colorectal Adenocarcinomas Share Biological Similarities with Micropapillary Patterns as well as Tumor BudsJournal of Korean Medical Science 2017; 32(10): 1595 doi: 10.3346/jkms.2017.32.10.1595
27
Giacomo Puppa, Carlo Senore, Kieran Sheahan, Michael Vieth, Alessandro Lugli, Inti Zlobec, Sara Pecori, Lai Mun Wang, Cord Langner, Hiroyuki Mitomi, Takatoshi Nakamura, Masahiko Watanabe, Hideki Ueno, Jacques Chasle, Stephen A Conley, Paulette Herlin, Gregory Y Lauwers, Mauro Risio. Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopyHistopathology 2012; 61(4): 562 doi: 10.1111/j.1365-2559.2012.04270.x
28
Eva Karamitopoulou, Inti Zlobec, Viktor Kölzer, Agathi Kondi-Pafiti, Efstratios S Patsouris, Konstantin Gennatas, Alessandro Lugli. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancerModern Pathology 2013; 26(2): 295 doi: 10.1038/modpathol.2012.155
29
Sang-Jeon Lee, Song Yi Choi, Wun-Jae Kim, Meiying Ji, Taek-Gu Lee, Bo-Ra Son, Soon Man Yoon, Rohyun Sung, Eun Jeoung Lee, Sei Jin Youn, Seon Mee Park. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patientsDiagnostic Pathology 2013; 8(1) doi: 10.1186/1746-1596-8-99
30
Nan Xie, Cheng Wang, Xiqiang Liu, Ruyao Li, Jinsong Hou, Xiaohua Chen, Hongzhang Huang. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinomaJournal of Oral Pathology & Medicine 2015; 44(4): 266 doi: 10.1111/jop.12242
31
Viktor H. Koelzer, Inti Zlobec, Alessandro Lugli. Tumor budding in colorectal cancer—ready for diagnostic practice?Human Pathology 2016; 47(1): 4 doi: 10.1016/j.humpath.2015.08.007
32
Stephen Olsen, Linda Jin, Ryan C. Fields, Yan Yan, ILKe Nalbantoglu. Tumor budding in intestinal-type gastric adenocarcinoma is associated with nodal metastasis and recurrenceHuman Pathology 2017; 68: 26 doi: 10.1016/j.humpath.2017.03.021